SCHEMBL26636833

SCHEMBL26636833

Cc1cc(OCC[C@H](C)C2CCNCC2)ccc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 7/20 0.37
▸ SLC6A2 P23975 5/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SLC6A3 Q01959 3/20 0.35
▸ HTR3A P46098 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ STAT3 P40763 1/20 0.34
▸ CHRNA3 P32297 1/20 0.34
▸ HAO1 Q9UJM8 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26635615 1.00 SLC6A4 (0.37) SLC6A4SLC6A2SIGMAR1SMN1; SMN2SLC6A3
SCHEMBL26635618 1.00 SLC6A4 (0.37) SLC6A4SLC6A2SIGMAR1SMN1; SMN2SLC6A3
SCHEMBL3228172 0.86 ALDH1A1 (0.42) SLC6A4SLC6A2SIGMAR1SLC6A3LMNA
SCHEMBL27810440 0.81 MAPK1 (0.41) SLC6A4SLC6A2MAPK1
SCHEMBL12103606 0.81 MAPK1 (0.41) SLC6A4SLC6A2MAPK1
Hydrochloric Acid SCHEMBL1295997 0.80 MAPK1 (0.40) SLC6A4SLC6A2SLC6A3MAPK1
Hydrochloric Acid SCHEMBL1295995 0.80 MAPK1 (0.40) SLC6A4SLC6A2SLC6A3MAPK1
SCHEMBL26619760 0.78 ITGB3 (0.45) SLC6A4SLC6A2SMN1; SMN2SLC6A3HTR3A
SCHEMBL31574984 0.77 ITGB3 (0.50) SLC6A4SLC6A2HTR3AKCNH2
SCHEMBL12103645 0.77 THRB (0.38) SLC6A4SLC6A2SLC6A3KDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519259-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. (US) 2025-03-12 — — EP disclosed
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. 2024-07-18 — — US disclosed
US-20230390404-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS TREELINE BIOSCIENCES INC (US) 2023-12-07 — — US disclosed
WO-2023215482-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. (US) 2023-11-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS BCL2A1, BCL2L1, BCL3 SLC6A4 3815/4885SLC6A2 2797/4885SIGMAR1 3279/4885
US-20230390404-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS BCL2A1, BCL2L1, BCL3 SLC6A4 3815/4885SLC6A2 2797/4885SIGMAR1 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback